Article
Pharmacogenomics and Morphine.
Journal of clinical pharmacology - 1 Sept 2021
Ofoegbu Adaku, B Ettienne Earl
Abstract excerpt
Morphine is an opioid analgesic indicated in the treatment of acute and chronic moderate to severe pain. From a pharmacodynamic standpoint, morphine exerts its effects by agonizing mu-opioid receptors predominantly, resulting in analgesia and sedation. Pharmacokinetically, morphine is primarily metabolized in the liver via glucuronidation by the enzyme uridine diphosphate glucuronosyltransferase family 2 member...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
